ALGM
Allegro MicroSystems, Inc.
ALGM has the edge over ASTS overall, supported by lower modeled downside and stronger fundamentals.
ASTS
AST SpaceMobile, Inc.
ASTS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
ALGM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
ALGM's revenue, profitability, cash flow and balance sheet are all currently healthy.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ALGM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $3.95 | -88% |
| Forward | 25x | $31.71 | — |
| Fair | 42x | $6.66 | -79% |
| Expensive | 60x | $9.54 | -70% |
| Current | 198x | $31.71 | — |
Historical ranges are pointers, not guarantees.
ALGM's PE is in its expensive range at 198x. If earnings grow as analysts expect, today's price would be 25x next year's earnings, in its cheap range.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
ALGM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for ALGM, with profitability improving.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ALGM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | +696% |
| Q3 2026 | $0.16 | +$0.32 |
| Q2 2026 | $0.07 | +$0.44 |
| Q1 2026 | -$0.08 | +$0.31 |
| Q4 2025 | -$0.08 | +$0.27 |
| Q3 2025 | -$0.16 | -$0.02 |
| Q2 2025 | -$0.37 | -197% |
| Q1 2025 | -$0.39 | -150% |
| Q4 2024 | -$0.35 | -130% |
ALGM has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
ALGM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $276.9M | +29% |
| Q2 2026 | $259.2M | +27% |
| Q1 2026 | $243.2M | +26% |
| Q4 2025 | $229.2M | +29% |
| Q3 2025 | $214.3M | +14% |
| Q2 2025 | $203.4M | +22% |
| Q1 2025 | $192.8M | -20% |
| Q4 2024 | $177.9M | -30% |
ALGM's revenue has grown year over year for six quarters in a row: $277M last quarter, up 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +9.9 points |
| Q2 2026 | 9.8% | +11 points |
| Q1 2026 | 2.2% | +9.1 points |
| Q4 2025 | 4.2% | +4.2 points |
| Q3 2025 | 2.9% | +0.7 points |
| Q2 2025 | -1.4% | +5 points |
| Q1 2025 | -6.8% | -13 points |
| Q4 2024 | 0% | -14 points |
ALGM has the edge over ASTS on profitability, with a higher operating margin.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over ALGM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
ALGM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $30.5M | +119% |
| Q2 2026 | $14M | -73% |
| Q1 2026 | $18.7M | +25% |
| Q4 2025 | $41.3M | +$63.1M |
| Q3 2025 | $13.9M | +150% |
| Q2 2025 | $51M | +120% |
| Q1 2025 | $15M | +$16.5M |
| Q4 2024 | -$21.8M | -157% |
ALGM has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
ALGM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -52.6K shares |
| 1 year | +0.8% | +1.4M shares |
| 3 years | -3.8% | -7.4M shares |
| 5 years | -2.1% | -4M shares |
| Available history | 0% | -32.5K shares |
ALGM has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | $116,000 |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
ALGM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 1.1x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 2.0x | Moderate |
| Q3 2025 | 3.1x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 5.0x | High |
| Q4 2024 | 3.0x | Moderate |
ALGM's net debt is less than a year of its operating earnings (EBITDA), down from 3.1 years a year ago.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ALGM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.3 | Neutral |
| Stochastic | 13.9 | Oversold |
ALGM's weekly RSI is 41 (neutral) and its Stochastic is 14 (oversold).
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
ALGM PE vs Technology Sector
| Metric | ALGM | Sector median | Relative |
|---|---|---|---|
| PE | 198x | 28x | 611% above |
| PE % | 91 | 38 | 53 pts above |
ALGM is trading at 198x earnings, a 611% premium to the Technology sector's median of 28x.
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
ALGM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.2 | 4.4% below |
| 20 week MA | $38.9 | 18% below |
| 50 week MA | $38.7 | 18% below |
| 100 week MA | $32.9 | 3.7% below |
| 200 week MA | $32.4 | 2.2% below |
ALGM is in a downtrend: it's below all five of its weekly moving averages, and 2.2% below its 200-week average.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over ALGM on trend strength, trading above more of its moving averages.
ALGM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.3 | $24.8 | +35% |
| 2021 | $24.8 | $34.5 | +39% |
| 2022 | $34.5 | $30.2 | -12% |
| 2023 | $30.2 | $30.3 | +0.1% |
| 2024 | $30.3 | $22.3 | -26% |
| 2025 | $22.3 | $26.9 | +21% |
| 2026 YTD | $26.9 | $31.7 | +18% |
ALGM has the edge over ASTS on returns for 2026, with the stronger performance.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.